Exploring New FDA Initiatives Under Commissioner Robert M. Califf

September 14, 2022 8:30am

Kurt R. Karst
Hyman, Phelps & McNamara, P.C. (Washington, D.C.)

Stacy Cline Amin
Morrison Forester (Washington, DC)
(Former Chief Counsel, U.S. FDA)

This panel will discuss how the Agency—now under the leadership of Dr. Califf will move forward with new initiatives including an evolving response to COVID-19 and examine key priorities. The Pre-Approval and Approval Process